More from Journal of Heart Valve Disease 15th Dec, 2023 Call to Action: Support and Contribute to The Journal of Heart Valve Disease 15th Dec, 2023 Important Announcement to the Scholarly Community: The Journal of Heart Valve Disease - Now Open Access ...
Anemia Caused by Erythropoietin Stimulating Agent in End-Stage Kidney Disease Patient Magbri A*, El-Magbri M and Hernandez PA Published :January, 2023 Abstract PDF Full-Text e-Pub Opinion Easy Steps of Management of Neonates with Congenital Heart Disease (CHD) ...
根据上文“At the end of the day, the research seems to agree that lowering your risk for heart disease is a combined effort.(最后,这项研究似乎一致认为,降低患心脏病的风险是需要综合努力的。)和下文“but instead can be significantly reduced with a balanced diet that follows many of the suggest...
《心肺移植杂志》(Journal Of Heart And Lung Transplantation)是一本以医学-呼吸系统综合研究为特色的国际期刊。该刊由Elsevier USA出版商创刊于1991年,刊期Monthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-呼吸系统领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学...
cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding ...
,like genetics,age,the amount of movement you get on a daily basis,and your diet,with many researchers believing that diet is the most crucial way to prevent these diseases.But how exactly do food and your daily diet impact your heart health and risk of disease?(2)...
Heart failure (HF), with its high morbidity and mortality, affects multiple aspects of a patient's life (e.g. physical, mental/emotional, and social), resulting in a reduction of quality of life (QoL).1 For optimal...
The Journal of Thoracic Disease describe new findings in the field provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease (lung disease, cardiology and esophagus disease).
These data elucidate the mechanisms by which transthyretin-reducing therapies modulate progression of cardiac disease and need to be confirmed in ongoing phase 3 trials.Patisiran可能会延迟从9岁开始的左心室功能障碍的进展;数月的治疗...
, disorders of the heart, variety of cardiology and heart health topics, including Bradycardia, Arrhythmias, Atherosclerosis, Atrial Fibrillation, cardiac remodelling, cardiomyopathy, Coronary artery disease, Mitral valve insufficiency, hypertension, myocardial ischemia, diabetes and other cardiovascular disease...